254 related articles for article (PubMed ID: 18494482)
21. Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.
Zhu P; Bi Y; Xu J; Li Z; Liu J; Zhang L; Ye W; Wu X
Bioorg Med Chem Lett; 2009 Dec; 19(24):6966-9. PubMed ID: 19889536
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Na+,K(+)-ATPase by flavonoids and their inotropic effect. Investigation of the structure-activity relationship.
Umarova FT; Khushbactova ZA; Batirov EH; Mekler VM
Membr Cell Biol; 1998; 12(1):27-40. PubMed ID: 9829256
[TBL] [Abstract][Full Text] [Related]
23. Identification of
Barr D; Szennyes E; Bokor É; Al-Oanzi ZH; Moffatt C; Kun S; Docsa T; Sipos Á; Davies MP; Mathomes RT; Snape TJ; Agius L; Somsák L; Hayes JM
ACS Chem Biol; 2019 Jul; 14(7):1460-1470. PubMed ID: 31243960
[TBL] [Abstract][Full Text] [Related]
24. Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
Klabunde T; Wendt KU; Kadereit D; Brachvogel V; Burger HJ; Herling AW; Oikonomakos NG; Kosmopoulou MN; Schmoll D; Sarubbi E; von Roedern E; Schönafinger K; Defossa E
J Med Chem; 2005 Oct; 48(20):6178-93. PubMed ID: 16190745
[TBL] [Abstract][Full Text] [Related]
25. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
26. Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.
Latsis T; Andersen B; Agius L
Biochem J; 2002 Nov; 368(Pt 1):309-16. PubMed ID: 12186629
[TBL] [Abstract][Full Text] [Related]
27. Regulation of glycogen metabolism in cultured human muscles by the glycogen phosphorylase inhibitor CP-91149.
Lerín C; Montell E; Nolasco T; García-Rocha M; Guinovart JJ; Gómez-Foix AM
Biochem J; 2004 Mar; 378(Pt 3):1073-7. PubMed ID: 14651477
[TBL] [Abstract][Full Text] [Related]
28. In vitro inhibition of glycogen-degrading enzymes and glycosidases by six-membered sugar mimics and their evaluation in cell cultures.
Kuriyama C; Kamiyama O; Ikeda K; Sanae F; Kato A; Adachi I; Imahori T; Takahata H; Okamoto T; Asano N
Bioorg Med Chem; 2008 Aug; 16(15):7330-6. PubMed ID: 18595718
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibition of diacylglycerol acyltransferase by prenylflavonoids from Sophora flavescens.
Chung MY; Rho MC; Ko JS; Ryu SY; Jeune KH; Kim K; Lee HS; Kim YK
Planta Med; 2004 Mar; 70(3):258-60. PubMed ID: 15114505
[TBL] [Abstract][Full Text] [Related]
30. Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b.
Kyriakis E; Stravodimos GA; Kantsadi AL; Chatzileontiadou DS; Skamnaki VT; Leonidas DD
FEBS Lett; 2015 Jul; 589(15):1787-94. PubMed ID: 25980608
[TBL] [Abstract][Full Text] [Related]
31. Pentacyclic triterpenes. Part 5: synthesis and SAR study of corosolic acid derivatives as inhibitors of glycogen phosphorylases.
Wen X; Xia J; Cheng K; Zhang L; Zhang P; Liu J; Zhang L; Ni P; Sun H
Bioorg Med Chem Lett; 2007 Nov; 17(21):5777-82. PubMed ID: 17869102
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationship of flavonoids for inhibition of epidermal growth factor-induced transformation of JB6 Cl 41 cells.
Ichimatsu D; Nomura M; Nakamura S; Moritani S; Yokogawa K; Kobayashi S; Nishioka T; Miyamoto K
Mol Carcinog; 2007 Jun; 46(6):436-45. PubMed ID: 17219438
[TBL] [Abstract][Full Text] [Related]
33. The interaction of flavonoids with mitochondria: effects on energetic processes.
Dorta DJ; Pigoso AA; Mingatto FE; Rodrigues T; Prado IM; Helena AF; Uyemura SA; Santos AC; Curti C
Chem Biol Interact; 2005 Apr; 152(2-3):67-78. PubMed ID: 15840381
[TBL] [Abstract][Full Text] [Related]
34. Studies of structure-activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
Loa J; Chow P; Zhang K
Cancer Chemother Pharmacol; 2009 May; 63(6):1007-16. PubMed ID: 18766342
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of quercetin on matrix metalloproteinase 9 activity molecular mechanism and structure-activity relationship of the flavonoid-enzyme interaction.
Saragusti AC; Ortega MG; Cabrera JL; Estrin DA; Marti MA; Chiabrando GA
Eur J Pharmacol; 2010 Oct; 644(1-3):138-45. PubMed ID: 20619256
[TBL] [Abstract][Full Text] [Related]
36. Flavonoids are potential inhibitors of glucose uptake in U937 cells.
Park JB
Biochem Biophys Res Commun; 1999 Jul; 260(2):568-74. PubMed ID: 10403807
[TBL] [Abstract][Full Text] [Related]
37. Flavonoid inhibition of overexpressed human 3beta-hydroxysteroid dehydrogenase type II.
Ohno S; Matsumoto N; Watanabe M; Nakajin S
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):175-82. PubMed ID: 15084349
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of phospholipase C gamma 1 by the prenylated flavonoids from Sophora flavescens.
Lee HS; Ko HR; Ryu SY; Oh WK; Kim BY; Ahn SC; Mheen TI; Ahn JS
Planta Med; 1997 Jun; 63(3):266-8. PubMed ID: 9225612
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of rat vas deferens contractions by flavonoids in-vitro.
Capasso R; Fiorino F; Ascione V; Frecentese F; Borrelli F
J Pharm Pharmacol; 2006 Mar; 58(3):381-4. PubMed ID: 16536906
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships of flavonoids for vascular relaxation in porcine coronary artery.
Xu YC; Leung SW; Yeung DK; Hu LH; Chen GH; Che CM; Man RY
Phytochemistry; 2007 Apr; 68(8):1179-88. PubMed ID: 17395220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
